The stock of Doximity Inc (NYSE:DOCS) last traded at $23.74, down -0.46% from the previous session.
DOCS stock price is now -7.90% away from the 50-day moving average and -6.50% away from the 200-day moving average. The market capitalization of the company currently stands at $4.43B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target maintained at $25, JP Morgan recently Upgraded its rating from Underweight to Neutral for Doximity Inc (NYSE: DOCS). On February 26, 2024, Leerink Partners recently initiated its ‘Market Perform’ rating on the stock quoting a target price of $32, while ‘Barclays’ rates the stock as ‘Equal Weight’
In other news, Wampler Kira Scherer, Director sold 2,500 shares of the company’s stock on Apr 01 ’24. The stock was sold for $67,425 at an average price of $26.97. Upon completion of the transaction, the Director now directly owns 10,258 shares in the company, valued at $0.24 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 01 ’24, Director Wampler Kira Scherer sold 2,500 shares of the business’s stock. A total of $69,700 was realized by selling the stock at an average price of $27.88. This leaves the insider owning 10,258 shares of the company worth $0.24 million. A total of 36.83% of the company’s stock is owned by insiders.
During the past 12 months, Doximity Inc has had a low of $19.71 and a high of $36.29. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 6.20, and a quick ratio of 7.97.
According to the Health Information Services Company, earnings per share came in at 0.2, beating analysts’ expectations of 0.17 by 0.03. This compares to $0.16 EPS in the same period last year. The net profit margin was 31.04% and return on equity was 15.81% for DOCS. The company reported revenue of $135.28 million for the quarter, compared to $115.26 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 17.37 percent. For the current quarter, analysts expect DOCS to generate $116.4M in revenue.
